Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae

In vivo induction of AmpC beta-lactamases produces high-level resistance to many beta-lactam antibiotics in Enterobacteriaceae, often resulting in the need to use carbapenems or cefepime (FEP). The clinical effectiveness of piperacillin-tazobactam (TZP), a weak inducer of AmpC beta-lactamases, is po...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Cheng, Lucy, Nelson, Brian C., Mehta, Monica, Seval, Nikhil, Park, Sarah, Giddins, Marla J., Shi, Qiuhu, Whittier, Susan, Gomez-Simmonds, Angela, Uhlemann, Anne-Catrin
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2017
Assuntos:
Clinical Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444164/
https://ncbi.nlm.nih.gov/pubmed/28320724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00276-17
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares